Advances in the recognition of tubal intraepithelial carcinoma - Applications to cancer screening and the pathogenesis of ovarian cancer

被引:126
作者
Lee, Y [1 ]
Medeiros, F [1 ]
Kindelberger, D [1 ]
Callahan, MJ [1 ]
Muto, MG [1 ]
Crum, CP [1 ]
机构
[1] Brigham & Womens Hosp, Dept Pathol, Div Womens & Perinatal Biol, Boston, MA 02115 USA
关键词
fallopian tube neoplasms; intraepithelial carcinoma; BRCA; ovarian neoplasms; p53;
D O I
10.1097/01.pap.0000201826.46978.e5
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Prophylactic salpingo-oophorectomies from women with BRCA mutations (BRCA+) have identified the tube as a frequent site of early pelvic serous carcinoma (tubal intraepithelial carcinoma [TIC]). These observations have implications for both the early recognition of pelvic serous carcinoma in susceptible women and determining the ultimate site of origin for pelvic serous carcinomas. Moreover, the unique pathology of TIC has shifted attention from the more exuberant proliferations mentioned in prior studies to a spectrum of neoplastic atypias that can be morphologically subtle. This review addresses a multitude of epithelial changes; benign, malignant, and an intriguing third group, which we term "p53 signatures," is found in benign, nonciliated epithelium and stain intensely positive for p53. Understanding all 3 is important for the proper management of women undergoing prophylactic salpingo-oophorectomy and possibly formulating an integrated model for the pathogenesis of serous carcinoma in the reproductive tract. A protocol for sectioning and extensively examining the fimbriated end (SEE-FIM), and its rationale, is described.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 32 条
[1]  
[Anonymous], DIAGNOSTIC GYNECOLOG
[2]  
BANNATYNE P, 1981, DIAGN GYNECOL OBSTET, V3, P49
[3]  
CALLAHAN MJ, 2006, SOC GYN ONC ANN M
[4]   Cancer of the ovary [J].
Cannistra, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24) :2519-2529
[5]   Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers [J].
Carcangiu, ML ;
Radice, P ;
Manoukian, S ;
Spatti, G ;
Gobbo, M ;
Pensotti, V ;
Crucianelli, R ;
Pasini, B .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2004, 23 (01) :35-40
[6]   Challenges in the early diagnosis and staging of fallopian-tube carcinomas associated with BRCA mutations [J].
Colgan, TJ .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2003, 22 (02) :109-120
[7]   Occult carcinoma in prophylactic oophorectomy specimens - Prevalence and association with BRCA germline mutation status [J].
Colgan, TJ ;
Murphy, J ;
Cole, DEC ;
Narod, S ;
Rosen, B .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (10) :1283-1289
[8]  
DALRYMPLE JC, 1989, CANCER, V64, P110, DOI 10.1002/1097-0142(19890701)64:1<110::AID-CNCR2820640120>3.0.CO
[9]  
2-5
[10]   Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers [J].
Finch, A ;
Shaw, P ;
Rosen, B ;
Murphy, J ;
Narod, SA ;
Colgan, TJ .
GYNECOLOGIC ONCOLOGY, 2006, 100 (01) :58-64